Scientific publications

Nature Aging, 2024
IL-23R is a senescence-linked circulating and tissue biomarker of aging

Carver C., Rodriguez S., Atkinson E. et al.

International Journal of Molecular Sciences, 2025
The Proteome of Acute Muscle Pain: Observations from Acute Hypertonic-Saline-Induced Pain in Humans

Jubin P., Amigo M., Boulton D. et al.

Circulation, 2025
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Hundertmark M., Birkhoelzer S., Portwood C. et al.

Journal of Human Immunity, 2025
Markers of immune dysregulation in pediatric patients with severe bronchiolitis

Hickey K., Gruber C., Buta-Panov S. et al.

Molecular Metabolism, 2025
Deciphering tissue-specific protein regulation for insights into cardiometabolic disease

Hartley A., Sukhavasi K., Hu S. et al.

Scientific Reports, 2025
The moderating role of diet and physical activity in insulin resistance and immunometabolic depression

Gruber J., Schiweck C., Ruf A. et al.

International Journal of Molecular Sciences, 2025
Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

González-Montero M., Andrés-Rodríguez J., Criado M. et al.

Frontiers in Oncology, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors

Gill D., Cowey C., Daniels G. et al.

Bioscience Reports, 2025
Serum proteomics mirrors the histopathological changes underlying different etiologies of primary mitral valve disease

Garcia-Peña A., Ibarrola J., Segur M. et al.

Advanced Science, 2025
A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk

Gan X., Wei Y., Wu Y. et al.

Journal of the American Heart Association, 2025
Genetic Downregulation of Interleukin‐6 Signaling, Coagulation Function, and Risk of Thromboembolic Disease

Daghlas I., Gill D.

Journal of the American Heart Association, 2025
Circulating Proteins Associated With Myocardial Interstitial Fibrosis

Cunningham J., Wijdeveld L., Nauffal V. et al.

Pancreas, 2025
Plasma Proteomics Identifies Potential Pancreatic Cancer Risk Indicators in Type 2 Diabetes

Chu S., Liu J., Liu X. et al.

Cytokine, 2025
Associations between plasma ANGPTL4 levels and the risk of 24 cancers: a prospective cohort study

Cheng X., Zhao S., Du M. et al.

Medicine, 2025
A two-sample Mendelian randomization analysis of the impact of GABA receptor subtypes on human height

Chen L., Zeng Z., Wu M. et al.

Cancer Immunology, Immunotherapy, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Changoer P., Peng C., van Houten P. et al.

Journal of the Endocrine Society, 2025
Urinary Proteomics as a Noninvasive Readout of Obesity-associated Inflammation

Canki E., Kho E., van Stiphout R. et al.

Journal of the European Academy of Dermatology and Venereology, 2025
High‐throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid

Calabrese L., Vallini G., Bonacchi L. et al.

PLOS One, 2025
Lack of association between loneliness, social isolation and inflammation in people living with HIV aged ≥50 years: Results from the sub-study “No One Alone-Gesida Study”

Blanco J., Albendin-Iglesias H., Negredo-Puigmal E. et al.

Atherosclerosis, 2025
Identifying plasma proteomic biomarkers for risk prediction and therapeutic targets of abdominal aortic aneurysm: Prospective cohort and Mendelian randomization analyses

Zhang Y., Huang Y., Gan X. et al.